Sabatolimab
N/A
Report date: 2025/04/25 16:01:51
Base Information
Drug NameSabatolimab
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[14]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[40]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A
Develop Information
Active CompaniesNovartis Pharma AgNovartis Pharma Stein AgThe University Of Texas MD Anderson Cancer Center +[4]
Inactive CompaniesN/A
Active Indications +[7]
Inactive Indications +[7]
Other Information
ATC CodeN/A
Related LinksN/A